Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Biostax Corp.

Get SEC filing alerts via email and in your feed for Biostax Corp.

BTAX

Biostax Corp.

About Biostax Corp.

Biostax Corp. operates in the pharmaceutical and biotechnology sectors, focusing on acquiring, developing, and commercializing innovative drug and health technology products. Utilizing a hub-and-spoke business model, it advances small-scale, early-stage programs through subsidiaries and partnerships. Key products target autoimmune, liver, and immune-related diseases, with markets in the U.S. and emerging international regions. The company emphasizes operational efficiency, flexible deal structures, and diversified risk across its portfolio.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Biostax Corp.

1
1
Biostax Corp. Biostax Corp. Reports Q3 2024 Financial Results with Reduced Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments